Eplivanserin

DB12177InvestigationalSmall molecule

Eplivanserin has been used in trials studying the treatment of Sleep, Insomnia, Chronic Pain, Fibromyalgia, and Primary Insomnia, among others.

Chemical structure of Eplivanserin
Mechanism
Curator reviewed
Formula / weight
C19H21FN2O2 · 328.387 g/mol (avg)
Also known as
Eplivanserine
Code names
SR-46349

Resolves to

Compound
UNII3CO94WO6DJCAS130579-75-8ChEMBLCHEMBL257704PubChem5486684
Structure
InChIKeyVAIOZOCLKVMIMN-PRJWTAEASA-NSMILESCN(C)CCO\N=C(\C=C\C1=CC=C(O)C=C1)/C1=CC=CC=C1F
Targets
P28223HTR2AP28335HTR2C

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
680Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Eplivanserin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In